Immix Biopharma (IMMX) EPS (Basic) (2021 - 2026)
Immix Biopharma (IMMX) reported EPS (Basic) of -$0.18 for Q1 2026, down 19.11% on a YoY basis from -$0.23 in Q1 2025, and down 148.86% sequentially from -$0.07 in Q4 2025.
Immix Biopharma (IMMX) EPS (Basic) (2021 - 2026) Analysis & Trends
Immix Biopharma (IMMX) has 6 years of EPS (Basic) data on file, last reported at -$0.18 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Basic) fell 19.11% year-over-year to -$0.18; the trailing twelve-month figure through Mar 2026 stood at -$0.48 (down 1702.08% YoY), and the FY2025 full-year result was -$0.64, down 1046.75% from the prior year.
- EPS (Basic) eased to -$0.18 in Q1 2026, from -$0.07 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $0.54 in Q4 2024 to a low of -$0.24 in Q3 2024.
- A 5-year average of -$0.12 and a median of -$0.15 in 2024 frame the typical range for EPS (Basic).
- Across the five-year window, EPS (Basic) soared 1243.92% in 2024 and sank 113.53% in 2025, its largest moves.
- Tracing IMMX's EPS (Basic) over 5 years: stood at -$0.15 in 2022, then soared by 68.01% to -$0.05 in 2023, then soared by 1243.92% to $0.54 in 2024, then slumped by 113.53% to -$0.07 in 2025, then tumbled by 148.86% to -$0.18 in 2026.
- Business Quant data shows IMMX's EPS (Basic) at -$0.18 in Q1 2026, -$0.07 in Q4 2025, and -$0.24 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Immix Biopharma | 473.68 Mn | 473.68 Mn | - | -0.18 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.18 |
| Dec 31, 2025 | -0.07 |
| Sep 30, 2025 | -0.24 |
| Jun 30, 2025 | -0.22 |
| Mar 31, 2025 | -0.15 |
| Dec 31, 2024 | 0.54 |
| Sep 30, 2024 | -0.24 |
| Jun 30, 2024 | -0.15 |
| Mar 31, 2024 | -0.23 |
| Dec 31, 2023 | -0.05 |
| Sep 30, 2023 | -0.23 |
| Jun 30, 2023 | -0.24 |
| Mar 31, 2023 | -0.18 |
| Dec 31, 2022 | -0.15 |
| Sep 30, 2022 | -0.11 |
| Jun 30, 2022 | -0.11 |
| Mar 31, 2022 | -0.10 |
| Dec 31, 2021 | -6.20 |
| Sep 30, 2021 | -0.12 |
| Jun 30, 2021 | -0.06 |